actiTENS iOS app
by Sublimed
actiTENS iOS app (SBM2AA210) is a medical device (FDA Class II) made by Sublimed, cleared under FDA 510(k) K252767 on 16 Jan 2026 (1 earlier submission) and listed in FDA GUDID since 24 Apr 2024 (UDI-DI B786SBM2AA2100), active as of 2 Nov 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k) | NumberK252767 | Date16 Jan 2026 | StatusActive |
| United States | GUDID listing | NumberB786SBM2AA2100 | Date24 Apr 2024 | StatusListed |
Official records
- FDA 510(k) database K252767
- FDA 510(k) database K202159
From the FDA record
- Device description
- actiTENS is a transcutaneous electrical nerve stimulation (TENS) medical device designed to manage chronic pain. The compact design and flexible shape of the actiTENS electrical impulse generator allows to fix it for daily use directly to the body of the patient. The impulse generator is delivered with a separate cradle which allows safely recharging its non- removable battery. The actiTENS is compatible with a selection of disposable electrodes and compatible connector cables transmit the electrical stimulation impulses to the targeted nerves according to the selected therapy. The electrical stimulation waveforms are biphasic and asymmetric. The actiTENS is controlled via a downloadable mobile app which allows the comfortable and simple selection of the adequate stimulation program. The actiTENS is intended to be used by the patient at home and also for therapeutic application by medical professionals.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K252767 decided 16 Jan 2026 Active
- FDA GUDID UDI-DI B786SBM2AA2100 listed 24 Apr 2024 Listed
Timeline
- Cleared FDA 510(k) K202159
- Listed FDA GUDID B786SBM2AA2100
- Cleared FDA 510(k) K252767
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- actiTENS
- Generic name
- Analgesic transcutaneous electrical nerve stimulation system
- Model / Ref / Catalog
- actiTENS iOS app, SBM2AA210
- Primary DI / UDI-DI
- B786SBM2AA2100
- FDA product code
- GZJ, IPF, NGX, NYN, NUH
- GMDN term
- Analgesic transcutaneous electrical nerve stimulation system
- Device class
- Class II
- Regulation number
- 882.5890, 890.5850
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Analgesic transcutaneous electrical nerve stimulation system.